BEGIN:VCALENDAR
VERSION:2.0
PRODID:https://github.com/derhansen/sf_event_mgt
METHOD:PUBLISH
BEGIN:VEVENT
UID:400-96@www.leopoldina.org
CLASS: PUBLIC
SUMMARY:Challenges in COVID-19 Vaccination
DESCRIPTION:Effective and secure vaccines against the novel coronavirus SAR
 S-CoV-2 – alongside better treatments – are the most promising way out of t
 he COVID-19 pandemic. Several vaccine candidates have already received use 
 authorization, many more are under development and are being tested in clin
 ical trials. However, there are still huge challenges ahead: Even after app
 roval, vaccines will not be available on a large scale immediately. Challen
 ges range from manufacturing bottlenecks and complex logistic requirements 
 like consistent cold storage to the provision of sufficient vaccination fac
 ilities with an adequately trained health care workforce. Challenges like v
 accine prioritization or inequities in terms of global allocation must be m
 et. How to build public trust to reach the necessary level of immunity in t
 he population or how to deal with potential misinformation about COVID-19 a
 nd vaccines are other questions that need to be addressed.\n\nThis virtual 
 panel discussion explores approaches to address these challenges in COVID-1
 9 vaccination from a scientific perspective. The event is jointly organized
  by the German National Academy of Sciences Leopoldina and the Indian Natio
 nal Science Academy (INSA).\n\nINSA and Leopoldina welcome the following ex
 perts to the podium:\n\n 	Professor Regina T. Riphahn, PhD, Vice-President 
 of German National Academy of Sciences Leopoldina (host) 	Professor Gagande
 ep Kang, PhD, Chair of the Immunization Technical Advisory Group for the WH
 O South East Asian Region, Fellow of the Indian National Science Academy (I
 NSA) 	Richard Hatchett, MD, Chief Executive Officer of the Coalition for Ep
 idemic Preparedness Innovations (CEPI) 	Professor Heidi Larson, PhD, Direct
 or of The Vaccine Confidence Project, London School of Hygiene & Tropical M
 edicine, United Kingdom 	Florian von der Mülbe, MBA, PhD, Chief Production 
 Officer and Co-Founder of CureVac, Germany \n\nThis panel discussion is par
 t of the Leopoldina International Virtual Panel Series. In July 2020, the L
 eopoldina launched a virtual format for global scientific exchange: Leopold
 ina International – a series of online panels organized by Leopoldina’s Int
 ernational Relations Department in cooperation with its international partn
 ers. Leopoldina International offers a virtual room for the global scientif
 ic community to convene and for the interested public to join the dialogue 
 with scientists. Previous topics have been “COVID-19 and Multimorbidity: Ho
 w to Deal with Multiple Infectious Diseases in Parallel?”, “The Hidden Cris
 is: Mental Health in Times of COVID-19” and “Contact Tracing Apps: Promisin
 g Tool in the Fight Against COVID-19?”.\n\nFurther Information\n\nFlyer (PD
 F)\n\nSpeakers Profiles (PDF)\n\nContact\n\nDr Ruth Narmann Deputy Head, In
 ternational Relations Department German National Academy of Sciences Leopol
 dinaTel. +49 (0)30 203 8997 432Email: ruth.narmann@leopoldina.orgChristian 
 Weidlich Senior Officer, International Relations DepartmentGerman National 
 Academy of Sciences LeopoldinaTel. +49 (0)345 472 39 868Email: christian.we
 idlich@leopoldina.org\n\nFurther events in the series\n\n Contact Tracing A
 pps (15 July 2020)\n\nMental Health in Times of COVID-19 (28 September 2020
 )\n\nCOVID-19 and Multimorbidity (26 November 2020)\n\nVideo recording of t
 he event\n\nDownload video (mp4)
LOCATION:Online
DTSTAMP:20251112T170935Z
DTSTART:20210203T100000Z
DTEND:20210203T111500Z
END:VEVENT
END:VCALENDAR